ମୁଣ୍ଡ ଓ ବେକ କ୍ୟାନ୍ସର
The SWOAR Trial Sparing of Swallowing and Aspiration Related Organs at Risk & Submandibular Gland With Intensity Modulated Radiotherapy Versus Standard IMRT in Head and Neck Squamous Cell Carcinomas
କେଉଁଠିକୁ ଯିବେ
ଏହି trial ପାଇଁ ଭାରତରେ ୧ଟି hospital ରୋଗୀଙ୍କୁ ନେଉଛି।
ରେଜିଷ୍ଟ୍ରି ସାରାଂଶ (ଟେକ୍ନିକାଲ୍)
The aim of SWOAR TRIAL is to test sparing of Dysphagia/ Aspiration risk structures (DARS) and contra lateral submandibular gland by IMRT. HNSCC of the oropharynx, larynx and the hypopharynx treated with radical concurrent chemoradiotherapy or radiotherapy will be included in the trial. Patients will be randomized to SWOAR IMRT or standard IMRT. Swallowing function will be evaluated the MD Anderson Dysphagia Inventory (MDADI) scoring. Difference in the mean composite score of MDADI, a patient-reported outcome, at 6 months post radiotherapy is the primary outcome of the trial. Secondary Object…
ସ୍ପୋନ୍ସର: ଅଲ୍ ଇଣ୍ଡିଆ ଇନଷ୍ଟିଚ୍ୟୁଟ୍ ଅଫ୍ ମେଡିକାଲ ସାଇନ୍ସେସ୍
କ୍ଲିନିକାଲ୍ ଟ୍ରାଏଲ୍ସ.ଗଭ୍ (ClinicalTrials.gov) ରେ NCT05187091
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ୍ ୧୧ ସେପ୍ଟେମ୍ବର ୨୦୨୬ · ଆମେ ପଢିଲୁ ୨୦ ଅକ୍ଟୋବର ୨୦୨୬